A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors (Q84560039)
Jump to navigation
Jump to search
scientific article published on 10 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors |
scientific article published on 10 July 2012 |
Statements
A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors (English)
Komal Jhaveri
Lee Rosen
Bryan Schneider
Linnea Chap
Alison Hannah
Ziyang Zhong